Frank A Workman, MD Internal Medicine - Hematology Medicare: Medicare Enrolled Practice Location: 1542 S Bloomington St, Greencastle, IN 46135 Phone: 765-655-2581 |
Dr. Troy Tolosa Quiz, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 Medic Way, Greencastle, IN 46135 Phone: 765-653-4633 Fax: 765-653-0562 |
George J Saliba, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1542 S Bloomington St, Greencastle, IN 46135 Phone: 765-301-7449 |
Lisa Lynn Martin, M.D. Internal Medicine - Adolescent Medicine Medicare: Accepting Medicare Assignments Practice Location: 1542 S Bloomington St, Suite 1300, Greencastle, IN 46135 Phone: 765-658-2700 Fax: 765-658-2703 |
News Archive
Naturally occurring pigments in berries, also known as anthocyanins, increase the function of the sirtuin 6 enzyme in cancer cells, a new study from the University of Eastern Finland shows. The regulation of this enzyme could open up new avenues for cancer treatment. The findings were published in Scientific Reports.
In a pilot study by a team of researchers at The University of Texas at Austin, crystalline particles of titanium dioxide - the most common white pigment in everyday products ranging from paint to candies - were found in pancreas specimens with Type 2 diabetes, suggesting that exposure to the white pigment is associated with the disease.
According to new research presented at Digestive Disease Week 2007 (DDW), lifestyle factors like choosing your diet regimen or ordering an appetizer for dinner may have a significant impact on the gastrointestinal (GI) system, affecting your risk for certain diseases, weight and general GI-related activity.
Using a standardized set of measurements will help health professionals more accurately diagnose malnutrition among children ages 1 month to 18 years, as well as improve their treatment, according to a new joint statement from the Academy of Nutrition and Dietetics and the American Society for Parenteral and Enteral Nutrition.
In recent human trials for a promising new class of drug designed to target the hepatitis C virus (HCV) without shutting down the immune system, some of the HCV strains being treated exhibited signs of drug resistance.
› Verified 2 days ago